お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、母乳オリゴ糖（HMO）の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に母乳オリゴ糖（HMO）市場を分類しています。
本レポートでは世界の母乳オリゴ糖（HMO）市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Abbott、Inbiose、Glycom、Chr. Hansen (Jennewein)、Elicityl SA、ZuChem

レポートは母乳オリゴ糖（HMO）の主要生産者を調査し、主要地域や国の消費状況も提供します。母乳オリゴ糖（HMO）の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    2'-FL & 3-FL
    LNT & LNnT, etc.

用途別の市場セグメント：
    Infant Formula
    Others

本レポートの詳細内容
本レポートは、世界の母乳オリゴ糖（HMO）市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて母乳オリゴ糖（HMO）市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の母乳オリゴ糖（HMO）生産量、成長率、市場シェアを調査している。

二. 消費面では、母乳オリゴ糖（HMO）の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの母乳オリゴ糖（HMO）売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の母乳オリゴ糖（HMO）市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本母乳オリゴ糖（HMO）のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：母乳オリゴ糖（HMO）のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 母乳オリゴ糖（HMO）の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける母乳オリゴ糖（HMO）の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章母乳オリゴ糖（HMO）メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：母乳オリゴ糖（HMO）の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：母乳オリゴ糖（HMO）の主要メーカーの概要を提供し、製品の説明と仕様、母乳オリゴ糖（HMO）の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：母乳オリゴ糖（HMO）の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Valued at US$ 864 million in 2024, the global Human Milk Oligosaccharides (HMO) market is forecast to reach US$ 3225 million by 2030, at a CAGR of 24.6% during the forecast period.
Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.
HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.
With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.

Market Development Opportunities and Key Drivers:
As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.
Market Risks:
Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.
Market Concentration:
Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.
Downstream Demand Trends:
The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.
Latest Technologies:
The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.
Report Includes
This report presents an overview of global market for Human Milk Oligosaccharides (HMO) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Milk Oligosaccharides (HMO), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Milk Oligosaccharides (HMO) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem, etc.
Market Segmentation
By Company
    Abbott
    Inbiose
    Glycom
    Chr. Hansen (Jennewein)
    Elicityl SA
    ZuChem

Segment by Type
    2'-FL & 3-FL
    LNT & LNnT, etc.

Segment by Application
    Infant Formula
    Others

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human Milk Oligosaccharides (HMO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Milk Oligosaccharides (HMO) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 2'-FL & 3-FL
 Table 3. Key Players of LNT & LNnT, etc.
 Table 4. Global Human Milk Oligosaccharides (HMO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 7. Global Human Milk Oligosaccharides (HMO) Market Share by Region (2020-2031)
 Table 8. Market Trends
 Table 9. Market Drivers
 Table 10. Market Challenges
 Table 11. Market Restraints
 Table 12. Global Human Milk Oligosaccharides (HMO) Revenue by Players (2020-2025) & (US$ Million)
 Table 13. Global Human Milk Oligosaccharides (HMO) Market Share by Players (2020-2025)
 Table 14. Global Top Human Milk Oligosaccharides (HMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2024)
 Table 15. Global Human Milk Oligosaccharides (HMO) Industry Ranking 2023 VS 2024
 Table 16. Global 5 Largest Players Market Share by Human Milk Oligosaccharides (HMO) Revenue (CR5 and HHI) & (2020-2025)
 Table 17. Global Key Players of Human Milk Oligosaccharides (HMO), Headquarters and Area Served
 Table 18. Global Key Players of Human Milk Oligosaccharides (HMO), Product and Application
 Table 19. Global Key Players of Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
 Table 20. Mergers & Acquisitions, Expansion Plans
 Table 21. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 22. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2020-2025)
 Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 24. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2026-2031)
 Table 25. Global Market Size by Application (2020-2025) & (US$ Million)
 Table 26. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2020-2025)
 Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 28. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2026-2031)
 Table 29. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 30. North America Market Size by Application (2020-2031) & (US$ Million)
 Table 31. North America Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)
 Table 35. Europe Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 37. China Market Size by Type (2020-2031) & (US$ Million)
 Table 38. China Market Size by Application (2020-2031) & (US$ Million)
 Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)
 Table 41. Asia Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
 Table 45. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 47. Abbott Company Details
 Table 48. Abbott Business Overview
 Table 49. Abbott Human Milk Oligosaccharides (HMO) Product
 Table 50. Abbott Revenue (2020-2025) & (US$ Million)
 Table 51. Abbott Recent Development
 Table 52. Inbiose Company Details
 Table 53. Inbiose Business Overview
 Table 54. Inbiose Human Milk Oligosaccharides (HMO) Product
 Table 55. Inbiose Revenue (2020-2025) & (US$ Million)
 Table 56. Inbiose Recent Development
 Table 57. Glycom Company Details
 Table 58. Glycom Business Overview
 Table 59. Glycom Human Milk Oligosaccharides (HMO) Product
 Table 60. Glycom Revenue (2020-2025) & (US$ Million)
 Table 61. Glycom Recent Development
 Table 62. Chr. Hansen (Jennewein) Company Details
 Table 63. Chr. Hansen (Jennewein) Business Overview
 Table 64. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product
 Table 65. Chr. Hansen (Jennewein) Revenue (2020-2025) & (US$ Million)
 Table 66. Chr. Hansen (Jennewein) Recent Development
 Table 67. Elicityl SA Company Details
 Table 68. Elicityl SA Business Overview
 Table 69. Elicityl SA Human Milk Oligosaccharides (HMO) Product
 Table 70. Elicityl SA Revenue (2020-2025) & (US$ Million)
 Table 71. Elicityl SA Recent Development
 Table 72. ZuChem Company Details
 Table 73. ZuChem Business Overview
 Table 74. ZuChem Human Milk Oligosaccharides (HMO) Product
 Table 75. ZuChem Revenue (2020-2025) & (US$ Million)
 Table 76. ZuChem Recent Development
 Table 77. Research Programs/Design for This Report
 Table 78. Key Data Information from Secondary Sources
 Table 79. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global Human Milk Oligosaccharides (HMO) Market Share by Type: 2024 VS 2031
 Figure 3. 2'-FL & 3-FL Features
 Figure 4. LNT & LNnT, etc. Features
 Figure 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Global Human Milk Oligosaccharides (HMO) Market Share by Application: 2024 VS 2031
 Figure 7. Infant Formula Case Studies
 Figure 8. Others Case Studies
 Figure 9. Human Milk Oligosaccharides (HMO) Report Years Considered
 Figure 10. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 11. Global Human Milk Oligosaccharides (HMO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Human Milk Oligosaccharides (HMO) Market Share by Region: 2024 VS 2031
 Figure 13. Global Human Milk Oligosaccharides (HMO) Market Share by Players in 2024
 Figure 14. Global Top Human Milk Oligosaccharides (HMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2024)
 Figure 15. The Top 10 and 5 Players Market Share by Human Milk Oligosaccharides (HMO) Revenue in 2024
 Figure 16. North America Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 17. North America Human Milk Oligosaccharides (HMO) Market Share by Type (2020-2031)
 Figure 18. North America Human Milk Oligosaccharides (HMO) Market Share by Application (2020-2031)
 Figure 19. North America Human Milk Oligosaccharides (HMO) Market Share by Country (2020-2031)
 Figure 20. United States Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Human Milk Oligosaccharides (HMO) Market Share by Type (2020-2031)
 Figure 24. Europe Human Milk Oligosaccharides (HMO) Market Share by Application (2020-2031)
 Figure 25. Europe Human Milk Oligosaccharides (HMO) Market Share by Country (2020-2031)
 Figure 26. Germany Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. China Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. China Human Milk Oligosaccharides (HMO) Market Share by Type (2020-2031)
 Figure 34. China Human Milk Oligosaccharides (HMO) Market Share by Application (2020-2031)
 Figure 35. Asia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia Human Milk Oligosaccharides (HMO) Market Share by Type (2020-2031)
 Figure 37. Asia Human Milk Oligosaccharides (HMO) Market Share by Application (2020-2031)
 Figure 38. Asia Human Milk Oligosaccharides (HMO) Market Share by Region (2020-2031)
 Figure 39. Japan Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Share by Type (2020-2031)
 Figure 47. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Share by Application (2020-2031)
 Figure 48. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Share by Country (2020-2031)
 Figure 49. Brazil Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Mexico Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Turkey Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Israel Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. GCC Countries Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Abbott Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2020-2025)
 Figure 56. Inbiose Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2020-2025)
 Figure 57. Glycom Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2020-2025)
 Figure 58. Chr. Hansen (Jennewein) Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2020-2025)
 Figure 59. Elicityl SA Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2020-2025)
 Figure 60. ZuChem Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed